CME Stock Tickeron detected bullish Stock Pattern: Three Rising Valleys CME on October 21, 2025, netting in a 6.50% gain over 3 weeks

GET DAILY SIGNALS

Get AI intraday signals

CME - CME Group

Ticker: CME

Company: CME Group

Gain: +6.5%

Confirmed: 10/21/25

Succeeded: 11/12/25

Total length: 27 days

On October 16, 2025, A.I.dvisor detected a Three Rising Valleys Pattern (Bullish) for CME Group (CME, $262.51). On October 21, 2025, A.I.dvisor confirmed the Bullish pattern, setting a target price of $283.89. 22 days later, on November 12, 2025, CME reached the target price resulting in a for traders who took a long position in the stock.

Momentum Indicator for CME turns positive, indicating new upward trend

CME saw its Momentum Indicator move above the 0 level on November 26, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 106 similar instances where the indicator turned positive. In of the 106 cases, the stock moved higher in the following days. The odds of a move higher are at .

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 55 cases where CME's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

CME moved above its 50-day moving average on November 04, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CME advanced for three days, in of 329 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for CME moved out of overbought territory on November 17, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 44 similar instances where the indicator moved out of overbought territory. In of the 44 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Moving Average Convergence Divergence Histogram (MACD) for CME turned negative on November 21, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CME declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CME broke above its upper Bollinger Band on November 07, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 61, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.593) is normal, around the industry mean (5.432). P/E Ratio (27.216) is within average values for comparable stocks, (28.933). Projected Growth (PEG Ratio) (5.940) is also within normal values, averaging (3.288). Dividend Yield (0.034) settles around the average of (0.024) among similar stocks. P/S Ratio (15.823) is also within normal values, averaging (12.526).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CME’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly weaker than average sales and a marginally profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.